Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring (DATACAP)

This study has been completed.
Vodafone UK Foundation
Centre of Statistics and Medicine (CSM, Oxford)
Oncology Clinical Trials Office (OCTO, Oxford)
Information provided by (Responsible Party):
University of Oxford Identifier:
First received: January 3, 2010
Last updated: July 24, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)